Evidence map›Paper›PMID 24935938›Full record

ArticleHypertension (Dallas, Tex. : 1979)2014

Sex-specific T-cell regulation of angiotensin II-dependent hypertension.

Hong Ji, Wei Zheng, Xiangjun Li, Jun Liu, Xie Wu, Monan Angela Zhang, Jason G Umans, Meredith Hay, Robert C Speth, Shannon E Dunn and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 130 citations in OpenAlex.

  1. Sex differences in TLR4 expression in SHR do not contribute to sex differences in blood pressure or the renal T cell profile.American journal of physiology. Regulatory, integrative and comparative physiology · 2022
    Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. HMGB1 drives T-cell activation in hypertensive males and females.American journal of physiology. Renal physiology · 2025
    Article
  15. Recent advances on immunity and hypertension: the new cells on the kidney block.American journal of physiology. Renal physiology · 2025
    Review
  16. The role of T cells in vascular aging, hypertension, and atherosclerosis.American journal of physiology. Heart and circulatory physiology · 2024
    Review
  17. Revisiting sex as a biological variable in hypertension research.The Journal of clinical investigation · 2024
    Review
  18. Article
  19. Immune and inflammatory mechanisms in hypertension.Nature reviews. Cardiology · 2024
    Review
  20. Review

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Hong JiFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.). jih@georgetown.edu.
Wei ZhengFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Xiangjun LiFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Jun LiuFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Xie WuFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Monan Angela ZhangFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Jason G UmansFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Meredith HayFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Robert C SpethFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Shannon E DunnFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Kathryn SandbergFrom the Department of Medicine and Center for the Study of Sex Differences in Health, Aging, and Disease (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.) and Department of Pharmacology and Physiology and Center for Development of Radioligands (R.C.S.), Georgetown University, Washington, DC; Department of Experimental Pharmacology and Toxicology, School of Pharmaceutical Science, Jilin University, Changchun, Jilin, People's Republic of China (X.L.); Biorepository and Biochemistry Laboratory, MedStar Health Research Institute, Hyattsville, MD (J.G.U.); Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC (H.J., W.Z., X.L., J.L., X.W., J.G.U., K.S.); Department of Physiology and the Evelyn F. McKnight Brain Institute, University of Arizona at Tucson (M.H.); Department of Pharmaceutical Sciences, College of Pharmacy, Nova South Eastern University, Fort Lauderdale, FL (R.C.S.); Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada (M.A.Z., S.E.D.); Department of Immunology, University of Toronto, Toronto, Ontario, Canada (M.A.Z., S.E.D.); and Women's College Research Institute, Toronto, Ontario, Canada (S.E.D.).
Eastern University · USSoutheastern University · USGeorgetown-Howard Universities Center for Clinical and Translational Science · USMedStar Health · USUniversity Health Network · CAUniversity of Arizona · USUniversity of Toronto · CA

Funding

Georgetown-Howard Universities Center for Clinical and Translational Science (GHUUL1TR000101 · NCATS · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2012 to 2015
$19.3M
HORMONAL REGULATION OF ANGIOTENSIN RECEPTORSR01AG019291 · NIA · GEORGETOWN UNIVERSITY · PI SANDBERG, KATHRYN L · 2001 to 2011
$3.2M
Immune Modulation of HypertensionR01HL119380 · NHLBI · GEORGETOWN UNIVERSITY · PI SANDBERG, KATHRYN L · 2015 to 2018
$2.4M
Gonadotropins in a female model of age-induced hypertensionR21AG039779 · NIA · GEORGETOWN UNIVERSITY · PI SANDBERG, KATHRYN L · 2011 to 2012
$388k
Ovarian hormone-independent sex chromosome effects in menopauseR21AG037832 · NIA · GEORGETOWN UNIVERSITY · PI JI, HONG · 2010 to 2011
$307k
NCATS NIH HHS UL1 TR000101NHLBI NIH HHS R01 HL119380NIA NIH HHS AG-037832NIA NIH HHS R01 AG019291NIA NIH HHS R21 AG037832NIA NIH HHS R21 AG039779
6 · The paper itself

Abstract

Studies suggest T cells modulate arterial pressure. Because robust sex differences exist in the immune system and in hypertension, we investigated sex differences in T-cell modulation of angiotensin II-induced increases in mean arterial pressure in male (M) and female (F) wild-type and recombination-activating-gene-1-deficient (Rag1(-/-)) mice. Sex differences in peak mean arterial pressure in wild-type were lost in Rag1(-/-) mice (mm Hg: wild-type-F, 136±4.9 versus wild-type-M, 153±1.7; P<0.02; Rag1(-/-)-F, 135±2.1 versus Rag1(-/-)-M, 141±3.8). Peak mean arterial pressure was 13 mm Hg higher after adoptive transfer of male (CD3(M)→Rag1(-/-)-M) versus female (CD3(F)→Rag1(-/-)-M) T cells. CD3(M)→Rag1(-/-)-M mice exhibited higher splenic frequencies of proinflammatory interleukin-17A (2.4-fold) and tumor necrosis factor-α (2.2-fold)-producing T cells and lower plasma levels (13-fold) and renal mRNA expression (2.4-fold) of interleukin-10, whereas CD3(F)→Rag1(-/-)-M mice displayed a higher activation state in general and T-helper-1-biased renal inflammation. Greater T-cell infiltration into perivascular adipose tissue and kidney associated with increased pressor responses to angiotensin II if the T cell donor was male but not female and these sex differences in T-cell subset expansion and tissue infiltration were maintained for 7 to 8 weeks within the male host. Thus, the adaptive immune response and role of pro- and anti-inflammatory cytokine signaling in hypertension are distinct between the sexes and need to be understood to improve therapeutics for hypertension-associated disease in both men and women.

Indexed as

Adaptive ImmunityAngiotensin IIAnimalsBlood PressureDisease Models, AnimalFemaleHeart RateHomeodomain ProteinsHypertensionInterleukin-10Interleukin-17MaleMiceMice, KnockoutSex FactorsT-LymphocytesAngiotensin IIHomeodomain ProteinsInterleukin-10Interleukin-17RAG-1 proteinTumor Necrosis Factor-alphaangiotensinshypertensioninterleukin 10 interleukin 17sex characteristicsT-lymphocytestumor necrosis factor-alpha

Identifiers

PMID24935938
PMCPMC4133294
OpenAlexW2120963937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.